History

PRUDENTAS is a Contract Research Organization registered in March 2007 and headquartered in Moscow, Russia. Starting with few professionals who used to work together previously PRUDENTAS has been growing up constantly.

2007 – First clients from US awarded their Proof-Of-Concept trials;

2008 – PRUDENTAS opens its office in Ukraine to run international Phase Ib/IIa trial of Monoclonal Antibody for Swiss biotech; Full service (through subcontractors) provided to sponsors;

2009 – Enrolled 1500 patients in 60 sites for Swiss Pharma; Strategic partnering with ChemDiv in translational research; first FIH trials conducted;

2010 – PRUDENTAS runs 20 trials for 20 clients – from Phase I (FIH) to Phase IV; repeated business for 5 clients.